Code Sepsis: Rapid Methods To Diagnose Sepsis and Detect Hematopathogens. Part II: Challenges to the Laboratory Diagnosis of Sepsis

Clinical Microbiology Newsletter

Volumn 32, Issue 6, 2010, Pages 41-49

  Wolk, Donna M ^a   Fiorello, Albert B ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BETA LACTAM ANTIBIOTIC; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHLORAMPHENICOL; FLUCONAZOLE; ISONIAZID; LINEZOLID; MACROLIDE; MUPICURIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROCALCITONIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; ASSAY; BACTEREMIA; BLOOD CULTURE; BLOODSTREAM INFECTION; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; HEALTH CARE COST; HUMAN; IMMUNE RESPONSE; LABORATORY DIAGNOSIS; MASS SPECTROMETRY; MICROORGANISM DETECTION; MORTALITY; NONHUMAN; PEPTIDE NUCLEIC ACID FLUORESCENCE IN SITU HYBRIDIZATION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEPSIS;

EID: 77649224956     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2010.03.001     Document Type: Article

References (83)

1. Fenollar F., and Raoult D. Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int. J. Antimicrob. Agents 30 Suppl. 1 (2007) S7-S15
2. Kumar A., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med. 34 (2006) 1589-1596
3. Diab M., El-Damarawy M., and Shemis M. Rapid identification of methicillin-resistant staphylococci bacteremia among intensive care unit patients. Medscape J. Med. 10 (2008) 126
4. Sturm P.D., et al. Performance of two tube coagulase methods for rapid identification of Staphylococcus aureus from blood cultures and their impact on antimicrobial management. Clin. Microbiol. Infect. 14 (2008) 510-513
5. Bennett K., and Sharp S.E. Rapid differentiation of methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus from blood cultures by use of a direct cefoxitin disk diffusion test. J Clin. Microbiol. 46 (2008) 3836-3838
6. Qian Q., Eichelberger K., and Kirby J.E. Rapid identification of Staphylococcus aureus in blood cultures by use of the direct tube coagulase test. J. Clin. Microbiol. 45 (2007) 2267-2269
7. Marlowe E.M., et al. Practical therapeutic application of the Oxoid PBP2′ latex agglutination test for the rapid identification of methicillin-resistant Staphylococcus aureus in blood cultures. Am. J. Clin. Pathol. 118 (2002) 287-291
8. Kristensen B., Hojbjerg T., and Schonheyder H.C. Rapid immunodiagnosis of streptococci and enterococci in blood cultures. APMIS 109 (2001) 284-288
9. Terlecka J.A., et al. Rapid differentiation of Candida albicans from non-albicans species by germ tube test directly from BacTAlert blood culture bottles. Mycoses 50 (2007) 48-51
10. Harriau P., Ruffel F., and Lardy J.B. Use of BioRad plating agar MRSASelect for the daily detection of methicillin resistant staphylococci isolated from samples taken from blood culture bottles. Pathol. Biol. (Paris) 54 (2006) 506-509
11. Chan W.W., Lovgren M., and Tyrrell G.J. Utility of the pneumoslide test in identification of Streptococcus pneumoniae in blood cultures and its relation to capsular serotype. J. Clin. Microbiol. 47 (2009) 1559-1561
12. Bruins M.J., et al. Identification and susceptibility testing of Enterobacteriaceae and Pseudomonas aeruginosa by direct inoculation from positive BACTEC blood culture bottles into Vitek 2. J Clin. Microbiol. 42 (2004) 7-11
13. Chen J.R., et al. Rapid identification and susceptibility testing using the VITEK 2 system using culture fluids from positive BacT/ALERT blood cultures. J. Microbiol. Immunol. Infect. 41 (2008) 259-264
14. Chung J.W., et al. Evaluation of MicroScan and Phoenix system for rapid identification and susceptibility testing using direct inoculation from positive BACTEC blood culture bottles. Korean J. Lab. Med. 29 (2009) 25-34
15. Funke G., and Funke-Kissling P. Use of the BD PHOENIX Automated Microbiology System for direct identification and susceptibility testing of gram-negative rods from positive blood cultures in a three-phase trial. J. Clin. Microbiol. 42 (2004) 1466-1470
16. Ling T.K., Liu Z.K., and Cheng A.F. Evaluation of the VITEK 2 system for rapid direct identification and susceptibility testing of gram-negative bacilli from positive blood cultures. J. Clin. Microbiol. 41 (2003) 4705-4707
17. Wellinghausen N.T., et al. Evaluation of the Merlin MICRONAUT system for rapid direct susceptibility testing of gram-positive cocci and gram-negative bacilli from positive blood cultures. J. Clin. Microbiol. 45 (2007) 789-795
18. Avolio M., et al. Direct antifungal susceptibility testing of positive Candida blood cultures by Sensititre YeastOne. New Microbiol. 32 (2009) 179-184
19. Hunfeld K.P., et al. Molecular biological detection of pathogens in patients with sepsis. Potentials, limitations and perspectives. Anaesthesist 57 (2008) 326-337
20. Osborn T.M., Nguyen H.B., and Rivers E.P. Emergency medicine and the surviving sepsis campaign: an international approach to managing severe sepsis and septic shock. Ann. Emerg. Med. 46 (2005) 228-231
21. Rivers E., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 345 (2001) 1368-1377
22. Rivers E.P., et al. Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. Can. Med. Assoc. J. 173 (2005) 1054-1065
23. Adelson M.E., et al. Simultaneous detection of herpes simplex virus types 1 and 2 by real-time PCR and pyrosequencing. J. Clin. Virol. 33 (2005) 25-34
24. Gonzalez V., et al. Rapid diagnosis of Staphylococcus aureus bacteremia using S. aureus PNA FISH. Eur. J. Clin. Microbiol. Infect. Dis. 23 (2004) 396-398
25. Oliveira K., et al. Direct identification of Staphylococcus aureus from positive blood culture bottles. J. Clin. Microbiol. 41 (2003) 889-891
26. Oliveira K., et al. Differentiation of Candida albicans and Candida dubliniensis by fluorescent in situ hybridization with peptide nucleic acid probes. J. Clin. Microbiol. 39 (2001) 4138-4141
27. Oliveira K., et al. Rapid identification of Staphylococcus aureus directly from blood cultures by fluorescence in situ hybridization with peptide nucleic acid probes. J. Clin. Microbiol. 40 (2002) 247-251
28. Rigby S., et al. Fluorescence in situ hybridization with peptide nucleic acid probes for rapid identification of Candida albicans directly from blood culture bottles. J. Clin. Microbiol. 40 (2002) 2182-2186
29. Sogaard M., Stender H., and Schonheyder H.C. Direct identification of major blood culture pathogens, including Pseudomonas aeruginosa and Escherichia coli, by a panel of fluorescence in situ hybridization assays using peptide nucleic acid probes. J. Clin. Microbiol. 43 (2005) 1947-1949
30. Stender H. PNA FISH: an intelligent stain for rapid diagnosis of infectious diseases. Exp. Rev. Mol. Diagn. 3 (2003) 649-655
31. Wilson D.A., et al. Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures. J. Clin. Microbiol. 43 (2005) 2909-2912
32. Alexander B.D., et al. Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. Diagn. Microbiol. Infect. Dis. 54 (2006) 277-282
33. Hartmann H., et al. Rapid identification of Staphylococcus aureus in blood cultures by a combination of fluorescence in situ hybridization using peptide nucleic acid probes and flow cytometry. J. Clin. Microbiol. 43 (2005) 4855-4857
34. Chapin K.C., and Musgnug M.C. Direct susceptibility testing of positive blood cultures by using Sensititre broth microdilution plates. J. Clin. Microbiol. 41 (2003) 4751-4754
35. Oliveria, K.M. et al. 2007. Rapid identification of S. aureus and differentiation between MRSA and MSSA from blood culture bottles using S. aureus PNA FISH and MRSA EVIGENE. Presented at the IDSA 2005 Annual Meeting.
36. Shepard J.R., et al. Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles. J. Clin. Microbiol. 46 (2008) 50-55
37. Reller M.E., et al. Use of peptide nucleic acid-fluorescence in situ hybridization for definitive, rapid identification of five common Candida species. J. Clin. Microbiol. 45 (2007) 3802-3803
38. Toombs, L. et al. 2006. Impact of peptide nucleic acid (PNA) fluorescence in situ hybridization (FISH) for enterococcocal blood stream infections. Presented at the IDSA 2006 Annual Meeting.
39. Forrest G.N., et al. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob. Agents Chemother. 52 (2008) 3558-3563
40. Forrest G.N., et al. Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. J. Antimicrob. Chemother. 58 (2006) 154-158
41. Ly T., et al. Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Ther. Clin. Risk Manag. 4 (2008) 637-640
42. Pappas P.G., et al. Guidelines for treatment of candidiasis. Clin. Infect. Dis. 38 (2004) 161-189
43. Forrest G.N., et al. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J. Clin. Microbiol. 44 (2006) 3381-3383
44. Wolk D.M., et al. Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays. J. Clin. Microbiol. 47 (2009) 823-826
45. Ito T., et al. Community-associated methicillin-resistant Staphylococcus aureus: current status and molecular epidemiological perspective. Kansenshogaku Zasshi 78 (2004) 459-469
46. Katayama Y., Zhang H.Z., and Chambers H.F. PBP 2a mutations producing very high-level resistance to beta-lactams. Antimicrob. Agents Chemother. 48 (2004) 453-459
47. Donnio P.Y., et al. Partial excision of the chromosomal cassette containing the methicillin resistance determinant results in methicillin-susceptible Staphy lococcus aureus. J. Clin. Microbiol. 43 (2005) 4191-4193
48. Francois P., et al. Evaluation of three molecular assays for rapid identification of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 45 (2007) 2011-2013
49. Stamper P.D., et al. Clinical validation of the molecular BD GeneOhm StaphSR assay for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in positive blood cultures. J. Clin. Microbiol. 45 (2007) 2191-2196
50. Grobner S., et al. Evaluation of the BD GeneOhm StaphSR assay for detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from spiked positive blood culture bottles. J. Clin. Microbiol. 47 (2009) 1689-1694
51. al-Nawas B., and Shah P.M. Procalcitonin in patients with and without immunosuppression and sepsis. Infection 24 (1996) 434-436
52. Chawes B.L., et al. Procalcitonin for early diagnosis of bacteraemia in children with cancer. Ugeskr. Laeger 169 (2007) 138-142
53. Giamarellos-Bourboulis E.J., et al. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?. Intensive Care Med. 28 (2002) 1351-1356
54. Reingardiene D. Procalcitonin as a marker of the systemic inflammatory response to infection. Medicina 40 (2004) 696-701
55. Sauer M., et al. Procalcitonin in comparison to C-reactive protein as markers of the course of sepsis in severely immunocompromised children after bone marrow transplantation. Klin. Padiatr. 212 (2000) 10-15
56. Schneider H.G., and Lam Q.T. Procalcitonin for the clinical laboratory: a review. Pathology 39 (2007) 383-390
57. Fernandez-Lopez L.A., et al. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr. Infect. Dis. J. 22 (2003) 895-903
58. van Rossum A.M., Wulkan R.W., and Oudesluys-Murphy A.M. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect. Dis. 4 (2004) 620-630
59. Muller B., et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit. Care Med. 28 (2000) 977-983
60. Kruger S., et al. Procalcitonin predicts patients at low riskof death from community-acquired pneumonia across all CRB-65 classes. Eur. Respir. J. 31 (2008) 349-355
61. Beghetti M., et al. Kinetics of procalcitonin, interleukin 6 and C-reactive protein after cardiopulmonary-bypass in children. Cardiol. Young. 13 (2003) 161-167
62. Meisner M., Adina H., and Schmidt J. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit. Care 10 (2006) R1
63. Brahms Aktiengesellschaft. 2006. Instruction manual BRAHMS PCT sensitive KRYPTOR product insert.
64. Fenollar F., and Raoult D. Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int. J. Antimicrob. Agents 30 Suppl. 1 (2007) S7-S15
65. Karahan Z.C., et al. PCR evaluation of false-positive signals from two automated blood-culture systems. J. Med. Microbiol. 55 (2006) 53-57
66. Marlowe E.M., and Wolk D.M. Pathogen detection in the genomic era. In: Tang Y. (Ed). Advanced techniques in diagnostic microbiology (2006), Springer Verlag, New York 505-523
67. Wolk D.M., and Marlowe E.M. Future trends in diagnosis of infections in the immunocompromised population. In: Hayden R.T., et al. (Ed). Diagnostic microbiology of the immunocompromised Host (2008), ASM Press, Washington, DC
68. Casalta J.P., et al. Evaluation of the LightCycler SeptiFast test in the rapid etiologic diagnostic of infectious endocarditis. Eur. J. Clin. Microbiol. Infect. Dis. 28 (2009) 569-573
69. Dierkes C., et al. Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis. BMC Infect. Dis. 9 (2009) 126
70. Mancini N., et al. Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies. J. Med. Microbiol. 57 (2008) 601-604
71. Jordan J.A., Butchko A.R., and Durso M.B. Use of pyrosequencing of 16S rRNA fragments to differentiate between bacteria responsible for neonatal sepsis. J. Mol. Diagn. 7 (2005) 105-110
72. Tang Y.W., et al. StaphPlex system for rapid and simultaneous identification of antibiotic resistance determinants and Panton-Valentine leukocidin detection of staphylococci from positive blood cultures. J. Clin. Microbiol. 45 (2007) 1867-1873
73. Baldwin C.D., et al. Usefulness of multilocus polymerase chain reaction followed by electrospray ionization mass spectrometry to identify a diverse panel of bacterial isolates. Diagn. Microbiol. Infect. Dis. 63 (2009) 403-408
74. Ecker D.J., et al. Molecular genotyping of microbes by multilocus PCR and mass spectrometry: a new tool for hospital infection control and public health surveillance. Methods Mol. Biol. 551 (2009) 71-87
75. Ecker D.J., et al. Ibis T5000: a universal biosensor approach for microbiology. Nat. Rev. Microbiol. 6 (2008) 553-558
76. Hujer K.M., et al. Rapid determination of quinolone resistance in Acinetobacter spp. J. Clin. Microbiol. 47 (2009) 1436-1442
77. Hall T.A., et al. Rapid molecular genotyping and clonal complex assignment of Staphylococcus aureus isolates by PCR coupled to electrospray ionization-mass spectrometry. J. Clin. Microbiol. 47 (2009) 1733-1741
78. Wolk D.M., et al. Rapid molecular characterization of S. aureus isolates by PCR/ESI-MS and correlation with phenotype (accpeted for publication). J. Clin. Microbiol. (2009)
79. Diekema D.J., et al. Rapid detection of antimicrobial-resistant organism carriage: an unmet clinical need. J. Clin. Microbiol. 42 (2004) 2879-2883
80. Fluit A.C., Visser M.R., and Schmitz F.J. Molecular detection of antimicrobial resistance. Clin. Microbiol. Rev. 14 (2001) 836-871
81. Rasheed J.K., and Tenover F.C. Detection and characterization of antimicrobial resistance genes in bacteria. In: Murray P.R., et al. (Ed). Manual of clinical microbiology (2003), ASM Press, Washington, DC 1196-1213
82. Tenover F.C., and Rasheed J.K. Detection of antimicrobial resistance genes and mutations associated with antimicrobial resistance in microorganisms. In: Persing D.H., et al. (Ed). Molecular microbiology: diagnostic principles and practice (2004), ASM Press, Washington, DC 391-406
83. Edlind T.D. Molecular detection of antifungal resistance. In: Persing D.H., et al. (Ed). Molecular microbiology: diagnostic principles and practice (2004), ASM Press, Washington, DC 569-575